ClearPoint Neuro (CLPT) “announced the U.S. Food and Drug Administration has granted marketing authorization for the SmartFlow Neuro Cannula using the De Novo pathway. The SmartFlow Neuro Cannula is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback